Nutritional deficiencies in patients with thalassemia

Annals of the New York Academy of Sciences

Volumn 1202, Issue , 2010, Pages 188-196

  Fung, Ellen B ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

iron, dietary intake; nutrition; thalassemia; vitamin D; zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIFEDIOL; COPPER; CYANOCOBALAMIN; ERGOCALCIFEROL; FERRITIN; FOLIC ACID; GAMMA TOCOPHEROL; PLACEBO; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; VITAMIN D; ZINC;

CLINICAL TRIAL; CONFERENCE PAPER; DIET THERAPY; DIETARY INTAKE; ENERGY EXPENDITURE; ERYTHROPOIESIS; GROWTH RETARDATION; HUMAN; IRON OVERLOAD; NUTRIENT; NUTRITIONAL DEFICIENCY; OBSERVATION; OXIDATIVE STRESS; PUBERTY DISORDERS; THALASSEMIA; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 77955855338     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05578.x     Document Type: Conference Paper

References (40)

1. American Academy of Pediatrics, Committee on Nutrition; 2008. Pediatric Nutrition Handbook, R.E. Kleinman, Eds., 6th ed. American Academy of Pediatrics. Elk Grove Village, IL.
2. Joint WHO/FAO Expert Committee. 2003. Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series, 916. WHO, Geneva, Switzerland.
3. Vogiatzi M., E.A.Macklin, F.L. Trachtenberg, et al. 2009. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassemia syndromes in North America. Br. J. Haematol. 146: 546-1156
4. De Sanctis V., A. Eleftheriou, C. Malaventura, et al. 2004. Prevalence of endocrine complications and short stature in patients with thalassemia major: a multicenter study by the Thalassemia International Federation (TIF). Pediatr. Endocrinol. Rev. (Suppl 2): 249-255.
5. Kwan E.Y.W., A.C.W. Lee, A.M.C. Li, et al. 1995. A crosssectional study of growth, puberty and endocrine function in patientswith thalassemiamajor inHongKong. J. Paediatr. Child Health 31: 83-87.
6. Fikry S.I., S.A. Saleh,N.N. Sarkis&H.Mangoud. 2003. Study of serum zinc in relation to nutritional status among thalassemia patients in DamanhourMedical National Institute. J. Egypt. Public Health Assoc. 78: 73-93.
7. Filosa A., S. Di Maio, G. Esposito, et al. 2001. Persistence of delayed adrenarche in boys with thalassemia. J. Pediatr. Endocrinol. 14: 407-414.
8. Tienboon P. 2003. Effect of nutrition support on immunity in paediatric patients with beta-thalassaemia major. Asia- Pac. J. Clin. Nutr. 12: 61-65.
9. Fuchs G.J., P. Tienboon, S. Linpisarn, et al. 1996.Nutritional factors and thalassemia major. Arch. Dis. Child. 74: 224-227.
10. SolimanA.T.,W. El-Matary, M.M. Fattah, et al. 2004. The effect of high-calorie diet onnutritional parameters of children with beta-thalassaemia major. Clin. Nutr. 23: 1153-1158.
11. VaismanN, A. Akivis,D.Sthoeger, et al. 1995.Resting energy expenditure in patients with thalassemia major. Am. J. Clin. Nutr. 61: 582-584.
12. Suh J.R., A.K. Herbig & P.J. Stover. 2001. New perspectives on folate catabolism. Annu. Rev. Nutr. 21: 255-282.
13. Ozdem S., A. Kupesiz & A. Yesilipek. 2008. Plasma homocysteine levels in patients with b-thalassemia major. Scand. J. Clin. Lab. Invest. 68: 134-139.
14. Walter P.B., E.B. Fung, Killilea D.W., et al. 2006. Oxidative stress and inflammation in iron-overloaded patients with-thalassaemia or sickle cell disease. Br. J. Haematol. 135: 254-263.
15. Lal A. 2010. Nutrition and Antioxidant Therapies in Thalassemia. Presented at the Ninth Cooley's Anemia Symposium, Oct. 21-24, 2009.
16. Suthutvoravut U., P. Hathirat, P. Sirichakwal, et al. 1993. Vitamin E status, glutathione peroxidase activity and the effect of vitamin E supplementation in children with thalassemia. J. Med. Assoc. Thai. 76(Suppl 2): 146-152.
17. Kajanchumpol S., T. Tatu, W. Sasanakul, et al. 1997. Zinc and copper status of thalassemia children. Southest Asian J. Trop. Med. Public Health 28: 877-880.
18. Claster S., J.C. Wood, L. Noetzli, et al. 2009. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am. J. Hematol. 84: 344-348.
19. Vogiatzi M., E.A. Macklin, E.B. Fung, et al. 2009. Bone disease in thalassemia: a frequent and still unresolved problem. J. Bone Miner. Res. 24: 543-557.
20. Fung E.B., Y. Xu, N. Olivieri, et al. 2010. Inadequate dietary intake in patients with thalassemia. Pediatric Blood & Cancer. 54, 6, 799. Abstract.
21. Holick M.F. & T.C. Chen 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87: 1080S-1086S.
22. Napoli N., E. Carmena, S. Bucchieri, et al. 2006. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 38: 888-892.
23. Soliman A., A. Adel, M.Wagdy, et al. 2008. Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr. Endocrinol. Rev. 6(Suppl 1): 149-154.
24. Holick M.F. 2008. Vitamin D: a D-Lightful health perspective. Nutr. Rev. 66(Suppl 2): S182-S194.
25. ChungM., E.M. Balk, M. Brendel, et al. 2009. VitaminDand Calcium: A Systematic Review of Health Outcomes. Evidence Report No 183. (Prepared by the Tufts Evidence Based Practice Center, under contract No. HHSA 290-2007-10055-I) AHRQ Publication No. 09-E015. Agency for Health Care Research and Quality, Rockville, MD.
26. Wood J.C., S. Claster, S. Carson, et al. 2008. Vitamin D deficiency, cardiac iron and cardiac function in thalassemia major. Br. J. Haematol. 141: 891-894.
27. Dimitriadou M., A. Christoforidis, M. Economou, et al. 2009. Elevated serumparahormonelevels are associatedwith myocardial iron load in patients with beta-thalassemia major. Eur. J. Haematol. Sept 10, Epub ahead of print.
28. El-Edel R.H., M.M. Ghonaim, O.M. Abo-Salem & F.M. El- Nemr. 2010. Bone mineral density and vitamin d receptor polymorphism in beta- thalassemiamajor. Pak. J. Pharm. Sci. 23: 89-96.
29. Belostotsky V., Z. Mughal & N.J. Webb. 2009. A single high dose of ergocalciferol can be used to boost 25-hydroxy vitamin D levels in children with kidney disease. Pediatr. Nephrol. 24: 625-626.
30. Boas S.R., J.R. Hageman, L.T. Ho & M. Liveris. 2009. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis J. Cyst. Fibrosis 8: 270-272.
31. Arcasoy A. & A.O. Cavdar. 1975. Changes in trace minerals (serum zinc, copper and magnesium) in thalassemia. Acta Haematol. 53: 341-346.
32. Bekheirnia M.R., A.A. Shamshirsaz,M. Kamgar, et al. 2004. Serum zinc and its relation to bone mineral density in betathalassemic adolescents. Biol. Trace Elem. Res. 97: 215-224.
33. Cianciulli P., D. Sollecito, F. Sorrentino, et al. 1994. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Int. 46: 467-470.
34. Uysal Z., N. Akar, S. Kemahli, et al. 1993. Desferrioxamine and urinary zinc excretion in b-thalassemia major. Pediatr. Hematol. Oncol. 10: 257-260.
35. Al-Refaie F.N., B. Wonke, D.C. Wickens, et al. 1994. Zinc concentration in patients with iron-overload receiving oral iron chelator 1,2-dimethyl-3- hydroxypyrid-4-one or desferrioxamine. J. Clin. Pathol. 47: 657-660.
36. Maclean K.H., J.L. Cleveland, J.B. Porter. 2001. Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. Blood 98: 3831-3839.
37. Arcasoy A., A.O. Cavdar, S. Cin, et al. 1987. Effects of zinc supplementation on linear growth in beta thalassemia (a new approach). Am. J. Hematol. 24: 127-136.
38. Shamshirsaz A.A., M.R. Bekheirnia,M. Kamgar, et al. 2007. Bone mineral density in Iranian adolescents and young adults with beta-thalassemiamajor. Pediatr.Hematol.Oncol. 24: 469-479.
39. Dehshal M.H., A.H. Hooghooghi, A. Kebryaeezadeh, et al. 2007. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients. Med. Sci. Monit. 13: CR235-CR239.
40. de Alarcon P.A., M.E. Donovan, G.B. Forbes, et al. 1979. Iron absorption in the thalasemia syndromes and its inhibition by tea.N. Engl. J. Med. 300: 5-8.